Mclean Fernside
162 Mountain Road, Princeton, Massachusetts, 01541
Harvard Medical School-affiliated McLean Fernside specializes in residential treatment plans that address the primary addiction as well as accompanying co-occurring psychiatric disorders. As part of our Signature Recovery Programs, McLean Fernside is a self-pay residential program providing unparalleled treatment in an unsurpassed setting. Our clinicians are experts in substance abuse recovery, rehabilitation and relapse prevention. They help to motivate individuals in their care to take the necessary steps to overcome addiction.
Facility Highlights
- McLean Hospital is top ranked by U.S. News & World Report
- McLean Hospital is top ranked by U.S. News & World Report
- Integration of empirically supported treatments with twelve-step and other self-help resources.
Specialization
Dialectical Behavior Therapy (DBT)
Dialectical Behavior Therapy is a type of cognitive-behavioral psychotherapy developed in the late 1980s by psychologist Marsha M. Linehan to help better treat borderline personality disorder. Since its development, it has also been used for the treatment of other kinds of mental health disorders.Integrated Group Therapy (IGT)
Integrated Group Therapy is a psychotherapy tool that not only treats an individual for both disorders at the same time, but it addresses both of the disorders in singular sessions as though there is one condition. The integrated group therapy methods are similar to cognitive behavioral therapies in that group members share their experiences over the course of the previous week. Rather than speaking only to whether they had success or relapse in their drug use, they also focus on their mood swings and other issues that relate to both disorders.
Facility Settings
- Private/Secluded
Meet the Staff
Rocco A. Iannucci, MDMedical Director, Fernside, Instructor in Psychiatry, Harvard Medical SchoolBoard certified in psychiatry and addiction psychiatry by the American Board of Psychiatry and Neurology, Dr. Iannucci is an instructor in psychiatry at Harvard Medical School. His clinical interests include treatment of people with severe substance use disorders and those with co-occurring mental health conditions. He has published on the treatment of addiction in residential programs, and on cocaine abuse.- Roger D. Weiss, MDChief, Division of Alcohol and Drug Abuse; Director, Alcohol and Drug Abuse Clinical Research Program, Professor of Psychiatry, Harvard Medical SchoolDr. Weiss’ career has focused on treatment and clinical research with substance-dependent patients. He has received numerous NIH grants, developing integrated group therapy, an evidence-based treatment for co-occurring bipolar and substance use disorders, and leading a multi-site treatment study of prescription opioid dependence. He has authored over 300 publications, including several books, and was vice chair of the American Psychiatric Association Task Force on Practice Guidelines for Patients with Substance Use Disorders.
